2. Peptides
  3. Peptide and Derivatives
  4. Others
 

Others (672):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P1860
    TNF-α (31-45), human 144796-71-4 99.77%
    TNF-α (31-45), human is a potent NF-kB pathway activator. TNF-αis a proinflammatory cytokine that induces necrosis or apoptosis. TNF alpha stimulates NF-κB pathway via TNFR2 promotes cancer growth, invasion, and metastasis.
    TNF-α (31-45), human
  • HY-P1902
    Cardiotoxin Analog (CTX) IV (6-12) 115722-23-1 99.20%
    Cardiotoxin Analog (CTX) IV (6-12) is a membrane active peptide that specifically targets negatively charged phospholipid membranes (such as phosphatidylserine and phosphatidylinositol) and can be isolated from the venom of the Taiwan cobra. Cardiotoxin Analog (CTX) IV (6-12) is a snake venom cardiotoxin that binds to cell membranes and embeds into lipid bilayers through hydrophobic interactions and electrostatic attraction, thereby destroying the stability of membrane structure. Cardiotoxin Analog (CTX) IV (6-12) can induce membrane lipid disorder and cell lysis, exhibiting hemolysis and cytotoxicity.
    Cardiotoxin Analog (CTX) IV (6-12)
  • HY-P1902A
    Cardiotoxin Analog (CTX) IV (6-12) TFA 2918768-05-3 99.53%
    Cardiotoxin Analog (CTX) IV (6-12) TFA is a membrane active peptide that specifically targets negatively charged phospholipid membranes (such as phosphatidylserine and phosphatidylinositol) and can be isolated from the venom of the Taiwan cobra. Cardiotoxin Analog (CTX) IV (6-12) TFA is a snake venom cardiotoxin that binds to cell membranes and embeds into lipid bilayers through hydrophobic interactions and electrostatic attraction, thereby destroying the stability of membrane structure. Cardiotoxin Analog (CTX) IV (6-12) TFA can induce membrane lipid disorder and cell lysis, exhibiting hemolysis and cytotoxicity.
    Cardiotoxin Analog (CTX) IV (6-12) TFA
  • HY-P1568A
    Flagelin 22 TFA
    Flagelin 22 TFA (Flagellin 22 TFA), a fragment of bacterial flagellin, is an effective elicitor in both plants and algae.
    Flagelin 22 TFA
  • HY-P2048A
    MOTS-c(human) acetate 98.97%
    MOTS-c (human) acetate is a blood-brain barrier-penetrating, mitochondrial-derived peptide that modulates the AMPK/PGC-1α pathway to enhance insulin sensitivity. MOTS-c (human) acetate inhibits the folate cycle and de novo purine synthesis, increases AICAR levels to activate AMPK, and then regulates the Nrf2/Keap1 antioxidant pathway and inhibits the NF-κB inflammatory pathway, while promoting mitochondrial biogenesis and energy metabolism. MOTS-c (human) acetate has the effects of improving glucose and lipid metabolism, anti-oxidative stress, anti-inflammatory and neuroprotection, and can be used in the study of type 2 diabetes, traumatic brain injury, inflammatory diseases and aging-related metabolic disorders.
    MOTS-c(human) acetate
  • HY-W342021
    Thr-Leu 50299-12-2 99.78%
    Thr-Leu is a dipeptide composed of threonine and leucine. Thr-Leu can be hydrolyzed in the peritoneal cavity to generate constituent amino acids, thereby increasing the osmotic pressure of the dialysate. Thr-Leu can be used for the kinetic study of amino acid-based peritoneal dialysis fluids.
    Thr-Leu
  • HY-W756654
    Homoglutathione TFA
    Homoglutathione (TFA) is a biological molecule.
    Homoglutathione TFA
  • HY-P4371A
    Hel 13-5 TFA 98.22%
    Hel 13-5 TFA is a monomeric synthetic peptide based on the N-terminal fragment of human SP-B. Hel 13-5 TFA is mainly α-helical and consists of 13 hydrophobic amino acid residues and 5 hydrophilic amino acid residues. Hel 13-5 TFA can be combined with phospholipids for the development of a model system for pulmonary surfactant.
    Hel 13-5 TFA
  • HY-P4632
    H-γ-Glu-Leu-OH 2566-39-4 99.67%
    H-γ-Glu-Leu-OH is a dipeptide consisting of γ-glutamic acid and leucine, terminated by a hydroxyl group.
    H-γ-Glu-Leu-OH
  • HY-P2528
    Enhanced Green Fluorescent Protein (EGFP) (200-208) 323198-39-6 98.97%
    Enhanced Green Fluorescent Protein (EGFP) (200-208) is a marker gene product derived from the jellyfish Aequorea Victoria. Enhanced Green Fluorescent Protein (EGFP) (200-208) is a common reporter protein and is easy to detect.
    Enhanced Green Fluorescent Protein (EGFP) (200-208)
  • HY-D0889
    Glycylglycine 556-50-3 99.90%
    Glycylglycine is a non-selective glycylglycine dipeptidase substrate and iNOS inhibitor. Glycylglycine can cross the cell membrane by passive diffusion and is hydrolyzed to glycine in the cell, participating in energy metabolism and antioxidant processes. Glycylglycine promotes spermatogonial stem cells (SSCs) proliferation, inhibits astrocyte overactivation and reduces nitric oxide (NO) release, while upregulating the expression of neurotrophic factors (such as PDGFA, FGF2, CNTF) to support nerve myelin repair. Glycylglycine can be used to study male reproductive biology (such as SSCs proliferation regulation) and neurodegenerative diseases (such as neuroprotective mechanisms in multiple sclerosis).
    Glycylglycine
  • HY-P3993A
    (Gly14)-Humanin (human) (acetate) 99.86%
    (Gly14)-Humanin (human) (14-Glycine-Humanin (human)) acetate is an analog of Humanin in which the 14th amino acid serine was replaced with glycine (Gly). (Gly14)-Humanin (human) acetate has anti-apoptotic and neuroprotective functions.
    (Gly14)-Humanin (human) (acetate)
  • HY-P1939
    Cyclo(L-Leu-L-Pro) 2873-36-1 99.84%
    Cyclo(L-Leu-L-Pro) is an inhibitory substance targeting to production of norsolorinic acid (NA，a precursor of aflatoxin)，which can be isolated from A. xylosoxidans NFRI-A1. Cyclo(L-Leu-L-Pro) inhibits accumulation of NA by A. parasiticus NFRI-95 and inhibits spore formation. Cyclo(L-Leu-L-Pro) inhibits aflatoxin production with an IC50 of 0.2 mg/mL in A. parasiticus SYS-4.
    Cyclo(L-Leu-L-Pro)
  • HY-W092109
    H-Phe-Trp-OH 24587-41-5 99.22%
    H-Phe-Trp-OH (Phenylalanyltryptophan) is an endogenous metabolite.
    H-Phe-Trp-OH
  • HY-101399
    γ-Glu-Phe 7432-24-8 99.82%
    γ-Glu-Phe (γ-Glutamylphenylalanine) is synthesized by Bacillus amyloliquefaciens (GBA) and Aspergillus oryzae (GAO). γ-Glu-Phe or the post-enzymatic reaction mixture enhances the umami intensity of commercial soy sauce and model chicken broth.
    γ-Glu-Phe
  • HY-W010276
    Gly-Sar 29816-01-1 99.56%
    Gly-Sar is a Glycine (HY-Y0966) derivative.
    Gly-Sar
  • HY-W015450
    D-Ala-D-Ala 923-16-0
    D-Ala-D-Ala is a bacterial endogenous metabolite. D-Ala-D-Ala constitutes the terminus of the peptide part of the peptidoglycan monomer unit and is involved in the transpeptidation reaction as the substrate. D-Ala-D-Ala is catalyzed by D-Alanine-D-Alanine ligase.
    D-Ala-D-Ala
  • HY-P1851A
    AGA-(C8R) HNG17, humanin derivative TFA 98.34%
    AGA-(C8R) HNG17, humanin derivative TFA is a potent humanin (HN) derivative. AGA-(C8R) HNG17, humanin derivative completely suppresses neuronal cell death by Alzheimer's disease-relevant insults.
    AGA-(C8R) HNG17, humanin derivative TFA
  • HY-P1027
    LEP(116-130)(mouse) 258276-95-8 98.13%
    LEP(116-130)(mouse) is a synthetic leptin peptide fragment.
    LEP(116-130)(mouse)
  • HY-112173
    Prolylleucine 61596-47-2 99.85%
    Prolylleucine is a dipeptide containing branched-chain amino acids. Prolylleucine can affect the circadian rhythms and behaviour of animals.
    Prolylleucine